Global Artificial Corneal Implants Market Size & Analysis, Share
In 2021, the market for Artificial Corneal Implants Market was worth $ 410 million US dollars. AMR Group projects that the market will reach US$ 697 million by 2031, growing at a CAGR of 6.2 percent between 2022 and 2031. Globally, there is a growing population with serious eye illnesses, and vision loss is emerging as a significant public health issue. The incidence of eye conditions including diabetic retinopathy and ocular hypertension (glaucoma) has surged due to the aging of the population and the rising prevalence of chronic illnesses like diabetes and hypertension. It is also anticipated that the population of blind or severely visually impaired people would rise significantly.
https://wemarketresearch.com/reports/request-free-sample-pdf/artificial-corneal-implants-market/908
Top
companies in the Artificial Corneal Implants Market are,
·
AJL Ophthalmic SA
·
Alabama Eye Bank
·
Inc., Alcon
·
Inc., Aurolab
·
Cornea Biosciences
·
CorneaGen Inc.
·
CorNeat Vision
·
DIOPTEX GmbH
·
EyeYon Medical
·
Florida Lions Eye Bank
·
KeraMed, Inc.
·
LinkoCare Life Sciences AB
·
Massachusetts Eye & Ear
·
Mediphacos
·
Presbia PLC
·
Price Vision Group and
·
San Diego Eye Bank among
·
others.
Market
Segments:
By Type
• Human Cornea
• Artificial Cornea
By Transplant Type
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior lamellar keratoplasty
By Application
• Keratoconus
• Fuchs Dystrophy
• Infectious Keratitis
• Corneal Ulcers
By End user
• Hospitals & Ambulatory Surgical Centers
• Specialty Clinics
This research report also
presents practical and practical case studies to help you get a clearer
understanding of the topic. This research report has been prepared through industry
analysis techniques and presented in a professional manner by including
effective information graphics whenever necessary. It helps ensure business
stability and rapid development to achieve notable remarks in the global Artificial
Corneal Implants market.
Market
Dynamics:
Drivers:
Regulatory approval: Strict protocols and rules apply to the development
and approval of corneal implants. Although these regulations are required to
ensure the efficacy and security of medical devices, they also provide challenges
for manufacturers and researchers in the corneal implant industry. Preclinical
testing and clinical trials are two of the stages of development that medical
products, including corneal implants, go through. The purpose of these tests is
to evaluate the implant's safety and effectiveness in treating specific ocular
conditions. Regulatory agencies such as the U.S. Food and Drug Administration
(FDA) in the United States and the European Medicines Agency (EMA) in Europe
require vast volumes of data to support safety and efficacy claims.
WE MARKET RESEARCH is an
established market analytics and research firm with a domain experience
sprawling across different industries. We have been working on multi-county
market studies right from our inception. Over the time, from our existence, we
have gained laurels for our deep rooted market studies and insightful analysis
of different markets.
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: sales@wemarketresearch.com
Comments
Post a Comment